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The BHV-5 strain N569 (BHV-5/N569) homolog to the BHV-1 US4 gene was sequenced and characterized. RNA analyses
showed that a 1.8-kb mRNA which contains the BHV-5/N569 US4 open reading frame initiates 55 nucleotides upstream
from the predicted translational start codon and terminates 17 nucleotides downstream from the consensus sequence for
polyadenylation. Comparison of the deduced amino acid sequences of the predicted US4 encoded proteins of BHV-5/N569
and BHV-1 strain Scho¨nbo¨ken (BHV-1/Scho¨) revealed 75% identity. An antiserum, raised in rabbits after infection with a
BHV-5/N569 US4 ORF expressing recombinant vaccinia virus, specifically precipitated a 65-kDa protein and a diffusely
migrating protein species with an apparent molecular mass between 90 and 240 kDa from the supernatant of BHV-5/
N569 infected cells. Treatment of immmunprecipitated proteins with chondroitinase AC demonstrated that the latter contains
glycosaminoglycans. The mobility of the BHV-5/N569 US4 gene products was identical to the BHV-1 US4 ORF encoded
glycoprotein G (gG) and glycoproteoglycan G (gpgG; G. M. Keil, T. Engelhardt, A. Karger, and M. Enz, J. Virol. 70, 3032–
3038, 1996) and were therefore named BHV-5 gG and BHV-5 gpgG. Immunoprecipitations with sera from BHV-1 infected
cattle indicated a type-specific immune response to gG, since these sera failed to react with vaccinia virus-expressed gG-
5 but recognized vaccinia virus-expressed gG-1. q 1996 Academic Press, Inc.
INTRODUCTION tion enzyme analysis of genomic DNA, by type-specific
antibodies, or by type-specific DNA hybridization probes
Bovine encephalitis herpesvirus, recently classified as
(Abdelmagid et al., 1995; Chowdhury, 1995; Engels et al.,
BHV-5 (Roizman et al., 1992), and infectious bovine rhino-
1987; Seal and Whetstone, 1994; Strube et al., 1992).
tracheitis herpesvirus (BHV-1) are alphaherpesviruses of
Although not analyzed in detail so far, it is reasonable
cattle which can cause severe clinical symptoms includ-
to assume that BHV-5 encodes a similar number of glyco-
ing respiratory and genital tract infections, conjunctivitis,
proteins as BHV-1, for which gB (Whitbeck et al., 1988),
and abortions (Gibbs and Rweyemamu, 1977; Wyler et
gC (Fitzpatrick et al., 1989), gD (Tikoo et al., 1990), gH
al., 1989). BHV-5 also exhibits a neuropathogenic poten-
(Baranowski et al., 1995), and gG and gpgG (Keil et al.,
tial and has been isolated from calves with (meningo)en-
1996) have been unequivocally assigned to their respec-
cephalitis in South America, Australia, and Europe (Cari-
tive genes. To date, genes and encoded proteins of BHV-
llo et al., 1983; French, 1962; Bartha et al., 1969). BHV-5
5 gC (Chowdhury, 1995) and BHV-5 gD (Abdelmagid et
and BHV-1 are closely related and intertypic recombi-
al., 1995; Strube et al., 1992) have been identified and
nants are viable (Keil et al., unpublished results). The
sequence comparisons demonstrated a high degree of
genomes of BHV-5 and BHV-1 are linear double-stranded
homology but also significant variations compared to the
DNA molecules of about 140 kb which have the typical
corresponding BHV-1 genes.
arrangement of herpesviral group D genomes (Roizman
In a recent report (Keil et al., 1996) it was shown that
et al., 1992), which are divided into unique long and short
the US4 open reading frame (ORF) of BHV-1/Scho¨ en-
regions, the latter being flanked by inverted repeat seg-
codes a primary translation product which is both N- and
ments. This results in the generation of two isomeric
O-glycosylated, resulting in a 70-kDa cellular and a 65-
genomes during replication of the viral DNA. On the ge-
kDa secreted gG. During intracellular transport, the ma-
nomic level BHV-5 and BHV-1 exibit 85% homology. How-
jority of the gG molecules are further modified to gpgG
ever, both species can be readily differentiated by restric-
by the addition of chondroitin sulfate. gpgG is also ex-
creted into the culture medium of infected cells and mi-
grates as a diffuse species between 90 and 240 kDa1 The nucleotide sequence data reported in this paper have been
submitted to the GenBank nucleotide sequence database under Acces- in SDS–polyacrylamide gels. Further analyses demon-
sion Nos. X99754 and X99755 for the BHV-1 and BHV-5 US4 sequences
strated that the US4 gene is not essential for BHV-1respectively.
replication in cell culture and no evidence was found2 To whom correspondence should be addressed. Fax: (49) 38351
7219. E-mail: Guenther.M.Keil@rie.bfav.de. that gG and gpgG might be associated with virions. Kaas-
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hoek et al. (1996) have shown that a BHV-1 US4 deletion Northern blot hybridization and nuclease S1
experimentsmutant exhibits a slightly attenuated phenotype in cattle.
To determine whether expression of a glycoproteogly-
Isolation of cyoplasmic RNA, gel electrophoresis, and
can, a hitherto unique feature of BHV-1, is shared by
transfer to nitrocellulose were done as described pre-
BHV-5, the US4 gene of BHV-5/N569 was sequenced and
viously (Maniatis et al., 1982). DNA probes used for hy-
characterized and the encoded proteins were identified
bridization were labeled with [a-32P]dCTP using a ran-
using an antiserum raised against recombinant vaccinia
dom-primed DNA labeling kit (Boehringer Mannheim,
virus expressing the BHV-5/N569 US4 ORF. Our results
Germany). S1 analysis using 5* or 3* end-labeled DNA
demonstrate that the BHV-5/N569 US4 gene encodes a
fragments and 5 mg cytoplasmic RNA isolated from non-
65-kDa glycoprotein and a high-molecular-weight glyo-
infected or BHV-5/N569 infected MDBK cells was per-
proteoglycan, which are designated as BHV-5 gG and
formed as described (Keil et al., 1987).
gpgG, respectively. We further show that sera from BHV-
1 infected cattle react type-specifically and do not recog- Antisera
nize BHV-5 gG in immunoprecipitation experiments.
To obtain antisera against US ORF4 encoded proteins,
two female littermates of outbred Chinchilla bastard rab-MATERIALS AND METHODS
bits were infected with 5 1 107 PFU VacgG-5 or VacgG-
Cells and viruses 1 and bled 4 weeks after a booster immunization with 5
1 107 PFU given 1 week after the initial infection. TheBHV-1/Scho¨ and BHV-5/N569 were obtained from O. C.
bovine hyperimmune serum against BHV-1/Scho¨ andStraub (Tu¨bingen, FRG) and propagated on Madin–
sera taken from BHV-5/N569 infected calves postmortemDarby bovine kidney cell clone Bu100 (MDBK; kindly pro-
were obtained from O. C. Straub (Tu¨bingen, Germany).vided by W. Lawrence and L. Bello, Philadelphia, PA).
Convalescent sera from BHV-5 infected calves wereCells were grown in Dulbecco’s minimum essential me-
kindly provided by J. Collins (Fort Collins, CO). Sera fromdium (DMEM) supplemented with 5% fetal calf serum
BHV-1 field virus infected cattle were kindly provided by(FCS), 100 U/ml penicillin, 100 mg/ml streptomycin, and
G. Hess (Koblenz, Germany).0.35 mg/ml L-glutamine. CV-1 cells used for the propaga-
tion of vaccinia viruses were maintained in the same Immunoprecipitation and glycosidase digestions
medium containing 10% FCS.
Confluent monolayers of MDBK-cells grown in 6-well
tissue culture dishes (Greiner, Nu¨rtingen, FRG) were in-Construction of US ORF4 expressing vaccinia virus
fected with a multiplicity of infection (m.o.i.) of 10. After
All cloning procedures followed established methods 1 hr of adsorption, the inoculum was replaced by 500 ml
(Maniatis et al., 1982). The plasmid for the generation DMEM lacking methionine and cysteine. After addition
of recombinant vaccinia viruses expressing BHV-5/N569 of [35S]methionine (500 mCi/ml) and [35S]cysteine (250
US4 ORF was obtained by insertion of a blunt-ended 1.9-
mCi/ml) cells were incubated for the times indicated and
kb DraIII fragment (see Fig. 1) into SmaI-cleaved vaccinia immunoprecipitations of proteins from cell culture super-
virus recombination vector pCS43 (Arnold et al., 1990) natants were carried out as described (Fehler et al.,
downstream from the vaccinia p7.5 promoter. The re- 1992). Labeled proteins were visualized after SDS–poly-
sulting plasmid was integrated into the genome of vac- acrylamide gel electrophoresis by fluorography. To re-
cinia virus strain WR following established procedures move N- or O-linked carbohydrates, immunoprecipitated
(Drillien and Spehner, 1983; Rapp et al., 1992) and the glycoproteins were incubated overnight at 377 with 0.4
recombinant vaccinia virus was named VacgG-5. U N-glycosidase F (Boehringer, Mannheim, Germany) or
1.5 mU O-glycosidase (Boehringer, Mannheim, Ger-Sequencing and sequence analyses
many). For removal of high-mannose N-glycans, immuno-
precipitates were digested with endo-b-N-acetylgluco-The DNA sequences of both strands were determined
with the dideoxy chain termination method (T7 sequenc- saminidase (endo H, Boehringer, Mannheim, Germany)
overnight at 377. All deglycosylation reactions were incu-ing kit, Pharmacia, Heidelberg, Germany) using appro-
priate subclones or specific synthetic oligonucleotides bated under conditions recommended by the supplier.
Chondroitinase AC (Sigma, Munich, Germany) digestionsas primers. Ambiguous results due to strong stops in the
sequencing reactions were clarified by the method of of immunoprecipitated proteins were performed in phos-
phate-buffered saline (PBS) for 5 hr at 377 after disinte-Maxam and Gilbert with modifications as described (Keil
et al., 1987). gration of the Staphylococcus aureus –antibody–antigen
complexes and removal of the bacteria as described (KeilNucleotide and amino acid sequence analysis was
performed using the Genetic Computer Group software et al., 1996). Reaction mixtures contained Chondroitinase
AC at a final concentration of 2.5 U/ml.package, Version 8.0-UNIX (Devereux et al., 1984).
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FIG. 1. Localization of the US4 genes of BHV-5/N569 and BHV-1/Scho¨. The HindIII restriction fragment maps for BHV-5/N569 (Engels et al., 1987;
Bulach and Studdert, 1990) and BHV-1 (Engels et al., 1987) are shown below a schematic diagram of the prototypic orientation of BHV-1 and -5
(Mayfield et al., 1983; Engels et al., 1987). The US segments encompassing the US4 genes of BHV-5/N569 (top) and BHV-1/Scho¨ (bottom) are
enlarged. Relevant restriction enzyme cleavage sites are indicated. Location and direction of transcription of genes predicted to encode the BHV-
1 protein kinase (US3), gG (US4), gI (US6), and gD (Leung-Tack et al., 1994) are indicated by arrows. Dotted (BHV-5/N569) and hatched (BHV-1/
Scho¨) boxes depict the compared sequences (see Fig. 2).
RESULTS of cycloheximide (100 mg/ml) or phosphonoacetic acid
(PAA, 250 mg/ml). After electrophoresis in denaturing 1%
Sequence analysis of BHV-5/N569 and BHV-1/Scho¨
agarose gels and transfer to nitrocellulose filters, the
US4 genes
RNAs were hybridized with a 32P-labeled 1.2-kb DraIII/
As expected from the sequence analysis of the US NruI DNA fragment containing most of the BHV-5/N569
segment of BHV-1 strain ST (Leung-Tack et al., 1994), US4 ORF (Fig. 1). The probe detected transcripts of 1.8
the ORFs coding for the predicted US4 homologs of BHV- and 3.5 kb in RNA isolated 4 hr p.i. (Fig. 3, lane 2) which
5/N569 and BHV-1/Scho¨ were found at a colinear posi- were also present in RNAs isolated 6 and 12 hr p.i. (Fig.
tion (Fig. 1). The 1320-bp US4 ORF of BHV-5/N569 and 3, lanes 3 and 4) and after synthesis for 12 hr in the
the 1329-bp US4 ORF of BHV-1/Scho¨ are flanked by char- presence of PAA (Fig. 3, lane 5) but did not hybridize to
acteristic eukaryotic transcriptional control sequences. RNA from cells infected in the presence of cycloheximide
As indicated in Fig. 2, ‘‘TATA’’ elements (5*-TATAA-3* ) (Fig. 3, lane 1). Detection of two transcripts by the US4
are preceded by ‘‘CAT’’ box-like sequences, and typical ORF probe was expected because no polyadenylation
polyadenylation signals (5*-AATAAA-3* ) are found down- consensus sequence was found between the stop codon
stream from the respective ORFs (Birnstiel et al., 1985; of the putative US3 ORF (not shown) and the predicted
McLauchlan et al., 1985). Comparison of the US4 nucleo- translational start codon of the US4 ORF. Based on the
tide sequences of BHV-5/N569 and BHV-1/Scho¨ revealed location of transcriptional control elements as deduced
82% homology. Alignment of the sequences (Fig. 2) from the nucleotide sequence and subsequently con-
shows numerous gaps from 1 to 30 bp in size. However, firmed by the determination of the 5* and 3* ends of the
within the ORFs the gaps comprise only single or multiple BHV-5/N569 US4 mRNA, it was concluded that the 1.8-
triplets. Thus, the two genes apparently have diverged kb RNA represents the US4 mRNA. This interpretation
by point mutations and insertions or deletions. Neverthe- was supported by hybridization of Northern blots with a
less, the sizes of the ORFs remained nearly identical. 1.6-kb 32P-labeled BstEII–DraIII DNA fragment encom-
passing the entire US3 ORF (Fig. 1). This probe did not
Expression kinetics of BHV-1/N569 US4 transcripts detect the 1.8-kb RNA but hybridized to the 3.5-kb tran-
script (Fig. 3, lanes 6–8), indicating that the 3.5-kb RNATo determine size and expression kinetics of the BHV-
represents a structurally bicistronic transcript encom-5/N569 US4 mRNA, cytoplasmic RNA was isolated at
different times after infection in the absence or presence passing the US3 and US4 ORFs.
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FIG. 2. Nucleotide sequences and sequence comparison of BHV-5/N569 and BHV-1/Scho¨ US4 genes. The comparison of the nucleotide sequences
of the US4 genes of BHV-5/N569 and BHV-1/Scho¨ are shown. Sequences encompass transcriptional control elements. The locations of ‘‘CAT’’ boxes,
‘‘TATA’’ boxes, and polyadenylation signals (poly(A)) are indicated. The BHV-5/N569 US4 mRNA transcriptional start position (5* r, m) and poly(A)
tract addition site (r 3*, m) are marked as are the translation initiation (Met) and termination (end) triplets and the restriction enzyme cleavage
sites used for the determination of the mRNA 5* (AvaI at nucleotide 271) and 3* (NruI at nucleotide 1287) ends. Nucleotide 1 of the BHV-1/Scho¨
sequence corresponds to nucleotide 3140 in the US sequence of BHV-1 strain ST (Leung-Tack et al., 1994).
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BHV-5/N569 and BHV-1/Scho¨ US4 amino acid
sequence analyses and comparison
The amino acid sequences of BHV-5/N569 and BHV-
1/Scho¨ US4 polypeptides shown in Fig. 5 were deduced
from the corresponding open reading frames. The pre-
dicted start codons of the BHV-5/N569 (ATG at position
113) and BHV-1/Scho¨ (ATG at position 134) US4 ORFs,
located 55 (BHV-5/N569) and 77 nt (BHV-1/Scho¨) down-
FIG. 3. Expression kinetics of the BHV-5/N569 US4 gene. Cyto- stream from the 5* cap site determined for BHV-5/N569,
plasmic RNA from BHV-5/N569 infected MDBK cells was isolated at 4
are contained in a consensus sequence of translation(lanes 1, 2, and 6), 6 (lanes 3 and 7), and 12 (lanes 4, 5, and 8) hr p.i.
initiation (A/GNNATGG, Kozak, 1986) with one substitu-RNA separated in lanes 1 and 6 was isolated from cells incubated with
cycloheximide (100 mg/ml). In lane 5, RNA purified from cells infected tion at /4 reading 5*-ATCATGC-3* for both viruses (Fig.
in the presence of PAA (250 mg/ml, lane 5) is shown. 5 mg RNA per 2). The ORFs terminate at nucleotide 1433 (BHV-5/N569)
lane was electrophoretically size fractionated in agarose gels and and nucleotide 1463 (BHV-1/Scho¨), respectively, and en-
transferred to nitrocellulose. Filters were hybridized to a 32P-labeled
code proteins of 430 and 433 amino acids with calculatedAvaI –NruI fragment (lanes 1 to 5) or to a 32P-labeled DNA BstEII–DraIII
molecular weights of 46.354 kDa for BHV-5/N569 andfragment (lanes 6 to 8). See Fig. 1 for location of the probes. Sizes of
transcripts are indicated in kilobases (kb). 46.713 kDa for BHV-1/Scho¨. The deduced amino acid
sequences of both polypeptides exhibit characteristics
typical for glycoproteins. Hydrophobic regions at the N-
Determination of the 5* and 3* ends of the BHV-5/ termini with cores of 17 (BHV-5/N569) and 16 (BHV-1/
N569 US4 transcript Scho¨) predominantly hydrophobic residues that are not
interrupted by charged amino acids represent good can-
Nuclease S1 protection experiments were performed didates for signal sequences. According to von Heijne’s
to precisely locate the ends of the BHV-5/N569 US4 rules, the signal peptides are probably cleaved after Gly26
mRNA. The 5* end was mapped with a 401-nt DNA frag-
ment which was 5* end-labeled at an AvaI cleavage site
at position 266 (see Fig. 2). After hybridization of the
probe to RNA isolated from infected cells 12 hr p.i. and
subsequent nuclease S1 digestion, two protected frag-
ments were detected by autoradiography after denatur-
ing polyacrylamide gel electrophoresis (Fig. 4, left). The
212-nt fragment indicates a transcription start site at po-
sition 59, 25 bp downstream from the putative TATA box.
This adenosine residue is surrounded by pyrimidines, as
is often found for eukaryotic transcription initiation sites
(Fig. 2). The 401-nt protected fragment corresponds to
the full length of the probe and probably results from
protection by the overlapping US3 transcript.
The 3* end of the US4 mRNA was determined with a
515-nt NruI/DraIII fragment, 3* end-labeled at the NruI site
at position 1288 (Fig. 2). Assay of RNA from infected cells
by nuclease S1 digestion yielded the protected full-length
probe and several fragments from 210 to 239 nt (Fig. 4,
right). The protected fragment of 239 nt locates the 3* FIG. 4. Determination of the 5* and 3* ends of the gG mRNA. Cyto-
plasmic RNA from noninfected MDBK cells (lanes m) or from MDBKend of the BHV-5/US4 mRNA 17 bp downstream from the
cells infected with BHV-5/N569 (lanes i), isolated 12 hr p.i., was hybrid-polyadenylation signal adjacent to a G/T cluster which is
ized to a 401-nucleotide DNA fragment which had been 5* end-labeledfrequently observed downstream from mRNA 3* termini
at the AvaI cleavage site indicated in Fig. 2 (left) or a 515-nucleotide
(McLauchlan et al., 1985). The smaller protected fragments DNA fragment which was 3* end-labeled at the NruI cleavage site
probably resulted from overdigestion of DNA/RNA hybrids indicated in Fig. 2 (right). After incubation with nuclease S1, fragments
were separated by electrophoresis in 6% denaturing polyacrylamidedue to incomplete hybridization or insufficient stability of
gels and visualized by autoradiography. Sizes of the protected frag-the heteroduplexes as a consequence of the AT-rich se-
ments and the labeled fragments before the nuclease treatment (lanesquences at the polyadenylation signal (Rapp et al., 1992). p) are given in nucleotides (n). As size markers sequencing ladders,
Protection of the complete labeled DNA probe might indi- 5* end-labeled HpaII cleavage products of pBR322 and the 123-bp
ladder (GIBCO-BRL) were used.cate the presence of read-through transcripts.
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FIG. 5. Sequence comparison and secondary structure analysis of the deduced BHV-5/N569 and BHV-1/Scho¨ US4 proteins. The alignment of the
deduced amino acid sequence is shown. Identical residues are connected by bars ( ) and conservative exchanges are marked by dots ( : ). Gaps
were introduced to maximize the alignment of identical amino acids. Cysteine residues are marked by asterisks and possible N-glycosylation sites
(NXS/T) are indicated. The predicted signal peptide cleavage site is indicated by an arrow and putative transmembrane domains near the carboxy-
terminus are marked by a dotted line. The hydropathy plots of the deduced amino acid sequences and the secondary structure predictions,
calculated by the methods of Kyte and Doolittle, and Chou and Fasman (Devereux et al., 1984), respectively, are shown below the alignment. Local
antigenic indices higher than 1.6 (octagons) were determined according to Jameson and Wolf (Devereux et al., 1984); location of N-glycosylation
consensus sequences are marked by lollipops; straight or squiggly lines and curves indicate b-sheets or a-helices and turns, respectively, as
defined by Chou and Fasman (1978).
(BHV-5) or Gly24 (BHV-1). Chou–Fasman analyses (Chou might represent membrane spanning domains, followed
by 30 mainly hydrophilic amino acids that probably formand Fasman, 1978) predict a b-turn structure preceding
the respective glycine residues, characteristic before or the cytoplasmic tails of the glycoproteins.
The amino acid sequences exhibit 75% identity andafter a signal peptidase recognition site (Kreil, 1981). The
putative extracellular portions of the polypeptides (Arg27 85% homology. From the alignment depicted in Fig. 5, it
can be seen that the regions with the greatest homologyto Arg385 for BHV-5/N569 and Arg25 to Arg388 for BHV-1/
Scho¨) contain 4 and 3 potential N-glycosylation consen- are located in domains with structural importance such
as the putative signal and membrane anchor sequencessus sequences, respectively. At the carboxy-terminus, 25
mainly highly hydrophobic amino acids (Ala386 to Cys 410 and N-glycosylation sites. The region between Tyr103 and
Gly203 of BHV-5/N569 gG (Tyr100 and Gly200 of BHV-1/Scho¨for BHV-5/N569 gG and Gly389 to Cys 413 for BHV-1/N569)
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(data not shown). The high-molecular-weight band seen
in all lanes is caused by a protein which is nonspecifi-
cally bound to the S. aureus used for immunoprecipita-
tion (Keil et al., 1996).
For the US4 encoded protein of BHV-1/Scho¨ it was
shown that the diffusely migrating high-molecular-weight
protein represents a glycoproteoglycan which consists
of chondroitin sulfate linked to a 65-kDa N- and O-glyco-
sylated glycoprotein (Keil et al., 1996). To demonstrate
that the diffusely migrating protein which is secreted into
the supernatant of BHV-5/N569 infected cells also con-
tains glycosaminoglycans, immunoprecipitates were in-FIG. 6. Identification of the BHV-5/N569 US4 protein. MDBK cells
cubated with PBS (Fig. 7, lane 1) or chondroitinase ACwere infected with BHV-5/N569 (lanes 1 and 3), VacgG-5 (lanes 2 and
4), and BHV-1/Scho¨ (lanes 5 and 6). [35S]Methionine- and [35S]cysteine- (Fig. 7, lane 2) and then analyzed by SDS–PAGE and
labeled proteins from the culture supernatants were immunoprecipi- fluorography. The result shows that chondroitinase AC
tated using the anti-VacgG-5 serum (lanes 1, 2, and 5) or the matching treatment of the high-molecular-weight protein specifiedpreimmune serum (lanes 3, 4, and 6). Precipitated proteins were sepa-
by BHV-5/N569 generated a 65-kDa protein, suggestingrated on an SDS–10% polyacrylamide gel and visualized by fluorogra-
that synthesis and processing of the BHV-5/N569 andphy. Apparent molecular masses are indicated in kilodaltons (kDa).
BHV-1/Scho¨ US4 ORF encoded products are compara-
ble. This conclusion was supported by digestion of immu-
gG), which encompasses four cysteine residues, is also noprecipitates with N-glycosidase F or neuraminidase
highly conserved not only among the two BHV US4 se- followed by O-glycosidase, which demonstrated that the
quences but also within the US4 homologs of herpes BHV-5/N569 65-kDa proteins also contain N- and O-
simplex virus (HSV)-2, pseudorabiesvirus (PRV), and linked carbohydrates (not shown). Therefore and in favor
equine herpesvirus (EHV)-1 and -4 (Leung-Tack et al., of a common nomenclature of homologous herpesviral
1994). The secondary structure predictions shown in Fig. (glyco)proteins, the high-molecular-weight glycoproteo-
5 indicate that the BHV-5/N569 and BHV-1/Scho¨ amino glycan and the 65-kDa glycoprotein encoded by BHV-5/
acid backbones may be folded differently. N569 were designated BHV-5 glycoproteoglycan G
(gpgG) and BHV-5 glycoprotein G (gG), respectively.
Identification of the BHV-5/N569 US4 gene encoded
gene product Type-specific reactivity of sera from BHV-1
infected cattleTo obtain a monospecific antiserum against the BHV-
5/N569 US4 encoded protein, the US4 ORF was inte- As shown in Fig. 6, the anti-VacgG-5 serum used in
grated into the genome of vaccinia virus strain WR and this report reacted with BHV-1/Scho¨ gG and gpgG. To
expressed under control of the P7.5 promoter. Rabbits
were infected with the recombinant vaccinia virus
VacgG-5 and the antiserum and the corresponding pre-
immune serum were used to immunoprecipitate [35S]-
methionine-cysteine labeled proteins from the superna-
tants of BHV-5/N569, BHV-1/Scho¨, and VacgG-5 infected
MDBK cells. From the supernatant of BHV-5/N569 in-
fected cells, the anti-VacgG-5 serum precipitated a pro-
tein which migrated as a diffuse high-molecular-weight
band and a barely visible polypeptide with an apparent
molecular weight of 65 kDa (Fig. 6, lane 1). The same
result was obtained when the anti-VacgG-5 serum was
used to immunoprecipitate labeled proteins from the me-
dium of BHV-1/Scho¨ infected cells (Fig. 6, lane 5). A 65- FIG. 7. The BHV-5/N569 US4 encoded high-molecular-weight protein
kDa protein but not the diffuse high-molecular-weight contains glycosaminoglycans. [35S]Methionine- and [35S]cysteine-la-
beled proteins from the culture supernatants of BHV-5/N569 infectedband was detected in immunoprecipitates from the su-
MDBK cells were immunoprecipitated with the anti-VacgG-5 serumpernatant of VacgG-5 infected cells (Fig. 6, lane 2). The
and incubated with PBS (lane 1) or chondroitinase AC (lane 2) afterdiffuse migrating protein and the 65-kDa polypeptide
disintegration of the S. aureus–antibody–antigen complexes in PBS at
were not precipitated by the matching preimmune serum 957 for 5 min and removal of the bacteria by low-speed centrifugation.
(Fig. 6, lanes 3, 4, and 6) or a rabbit serum raised against Digestion products were analyzed by SDS–10% polyacrylamide gel
electrophoresis and fluorography. The 65-kDa protein is indicated.a vaccinia virus recombinant expressing gD of BHV-1
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teins which were designated gG according to the proto-
type alphaherpesvirus HSV have up to now been charac-
terized for HSV-1 and -2 (Ackermann et al., 1986; Bala-
chandrian and Hutt-Fletcher, 1985; Richman et al., 1986;
Roizman et al., 1984), PRV (Rea et al., 1985), EHV-1 and
-4 (Telford et al., 1992; Crabb et al., 1992; Crabb et al.,
1993), and BHV-1/Scho¨ (Keil et al., 1996). In these alpha-
herpesviruses, the respective genes are located up-
stream of the gene coding for the essential glycoprotein
D. Given the common organization of the glycoproteinFIG. 8. Type specificity of a bovine hyperimmune serum to BHV-
1/Scho¨. [35S]Methionine- and [35S]cysteine-labeled proteins from the genes within the US region of HSV-1 and -2, PRV, EHV-
supernatants of VacgG-5 (lanes 1 to 3 ) or VacgG-1 (lanes 4 to 6) 1, and BHV-1, it was reasonable to assume that the BHV-
infected cells were immunoprecipitated with the rabbit anti-VacgG-5 5 US4 gene is located at a similar position. Therefore, aserum (lanes 1 and 4), a bovine anti-BHV-1/Scho¨ hyperimmune serum
2-kb nucleotide sequence upstream from the gD gene(lanes 3 and 6), or the matching bovine preimmune serum (lanes 2 and
of BHV-5/N569 and BHV-1/Scho¨ was determined. Align-5). Precipitated proteins were separated on an SDS–10% polyacryl-
amide gel and visualized by fluorography. Apparent molecular masses ment of the deduced amino acid sequences of BHV-5/
are indicated in kilodaltons (kDa). N569 and BHV-1/Scho¨ gG revealed 85% similarity and
75% identity, whereas comparison of the corresponding
sequences of BHV-1 strains Scho¨nbo¨ken and ST (Leung-test the reactivity of BHV-1 induced bovine antibodies
Tack et al., 1994) showed 96% identity and 97.5% similar-after infection with BHV-1, 35S-labeled proteins from su-
ity. The sequences around the predicted signal pepti-pernatants of cells infected with recombinant vaccinia
dase cleavage site and the primary structures of theviruses VacgG-5 (Fig. 8, lanes 1–3) and VacgG-1 (Fig.
putative membrane anchor domains are highly con-8, lanes 4–6) were immunoprecipitated using the anti-
served, as are the positions of all cysteine residues andVacgG-5 serum (Fig. 8, lanes 1 and 4), a hyperimmune
three of the four N-glycosylation signals found in BHV-serum from a BHV-1/Scho¨ infected calf that was chal-
5/N569. Comparison of the BHV gG amino acid se-lenged several times (Fig. 8, lanes 3 and 6) and the
quences with HSV-2, EHV-1, EHV-4, and PRV gG proteinsmatching preimmune serum (Fig. 8, lanes 2 and 5). In
showed that the highest homology is found within thecontrast to the anti-VacgG-5 serum that precipitated both
amino-terminal halves of the respective glycoproteinsgG-1 and gG-5, the bovine anti-BHV-1 hyperimmune se-
with a remarkable conservation of the location of cys-rum reacted only with gG-1. The bovine preimmune se-
teine residues (Keil et al., 1995). It is tempting to specu-rum did not precipitate any of the gG molecules. To eluci-
late that the tertiary structure of this part of the gG isdate whether BHV-1 positive field sera exhibit a similar
functionally important. However, the function of gG stilltype-specific reactivity and to test for cross reactivity of
remains obscure, since no significant phenotype couldthe anti-VacgG-1 serum, 35S-labeled proteins from super-
be assigned to HSV, PRV, and BHV-1 US4 deletion mu-natants of cells infected with VacgG-5 (Fig. 9, lanes 1 –
tants in cell culture and infected animals (Longnecker7) were incubated with the anti-VacgG-1 serum (Fig. 9,
and Roizman, 1987; Thomson et al., 1987; Kimman et al.,lane 1), the anti-VacgG-5 serum (Fig. 9, lane 2), and five
1992; Kaashoek et al., 1996).different field sera from BHV-1 infected bovines (Fig. 9,
lanes 3–7). As a control, the field sera were used to
immunoprecipitate 35S-labeled proteins from the culture
medium of VacgG-1 infected cells. As shown in Fig. 9,
the field sera from BHV-1 infected cattle precipitated de-
tectable amounts of gG only from the supernatants of
VacgG-1 infected cells (Fig. 9, lanes 8–12) whereas the
anti VacgG-1 serum also reacted with the VacgG-5-ex-
pressed gG (Fig. 9, lane 1. These results indicate that the
immune response of BHV-1 infected cattle as analyzed in
this assay appears to be type-specific with respect to
FIG. 9. Type specific reactivity of field sera. [35S]Methionine- andBHV-1 gG.
[35S]cysteine-labeled proteins from supernatants of VacgG-5 (lanes 1
to 7) or VacgG-1 (lanes 8 to 12) infected cells were immunoprecipitated
DISCUSSION with the rabbit anti-VacgG-1 serum (lane 1), the rabbit anti-VacgG-5
serum (lane 2), and five different field sera from BHV-1 infected cattle
This report describes the localization and characteriza- (lanes 3–12). Precipitated proteins were separated on an SDS–10%
tion of the BHV-5/N569 US4 gene and gene products. polyacrylamide gel and visualized by fluorography. Apparent molecular
masses are indicated in kilodaltons (kDa).Positionally homologous genes and the encoded pro-
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The BHV-5/N569 gG ORF is contained within two early both experimentally infected and field-virus infected ani-
mals reacted only with gG-1 secreted into the superna-transcripts of 1.8 and 3.5 kb similar to the BHV-1/Scho¨
ORF (Keil et al., 1996). Determination of RNA 5* and 3* tant of VacgG-1 infected cells. Unfortunately, sera from
BHV-5 infected calves did not recognize either BHV-5/ends showed that the 1.8-kb transcript constitutes the
gG mRNA and that the 3.5-kb RNA most probably repre- N569 gG or BHV-1/Scho¨ gG (not shown). Therefore, the
question whether BHV-5 also induces a type-specific im-sents a structurally bicistronic transcript which encom-
passes the putative protein kinase ORF and terminates mune response against gG in infected cattle awaits clari-
fication.at the gG polyadenylation signal. Although the 5* and 3*
ends for gG transcripts were determined for BHV-5/N569
only, we assume that the corresponding mRNA of BHV- ACKNOWLEDGMENTS
1/Scho¨ initiates and terminates at identical positions in
We thank Martina Enz for excellent technical assistance, Helmut
the BHV-1/Scho¨ genome because the sequences flank- Stephan and Elke Zorn for photography, and Thomas C. Mettenleiter
ing the 5* cap site and the poly(A) addition site of BHV- for critical reading of the manuscript. This work was financially sup-
ported by contract BIOT-CT90-0191-C(EDB) from the Commission of5/N569 are completely conserved in BHV-1/Scho¨.
the European Communities.For the detection and characterization of BHV-5 gG, a
specific antiserum was produced in rabbits infected with
REFERENCESrecombinant vaccinia viruses expressing the gG of BHV-
5/N569. From the medium of BHV-5/N569 infected cells, Abdelmagid, O. Y., Minocha, H. C., Collins, J. K., and Chowdhury, S. I.
the antiserum precipitated a protein with an apparent (1995). Fine mapping of bovine herpesvirus-1 (BHV-1) glycoprotein
D (gD) neutralizing epitopes by type-specific monoclonal antibodiesmolecular mass of 65 kDa and protein species migrating
and sequence comparison with BHV-5 gD. Virology 206, 242–253.in a very diffuse band ranging in size from 90 to greater
Ackermann, M., Longnecker, R., Roizman, B., and Pereira, L. (1986).than 240 kDa. The molecular masses and the migration
Identification, properties, and gene location of a novel glycoprotein
behavior in SDS–PAGE of the anti-VacgG-5 reactive pro- specified by herpes simplex virus 1. Virology 150, 207–220.
teins were identical to gG and gpgG encoded by the Arnold, B., Messerle, M., Jatsch, L., Ku¨hlbeck, G., and Koszinowski,
U. H. (1990). Transgenic mice expressing a soluble foreign H-2 classBHV-1/Scho¨ gG gene (Keil et al., 1996). Chondroitinase
I antigen are tolerant to allogeneic fragments presented by self classAC digestion of the diffusely migrating high-molecular-
I but not the whole membrane-bound alloantigen. Proc. Natl. Acad.weight protein, immunoprecipitated from the superna-
Sci. USA 87, 1762–1766.
tants of BHV-5/N569 infected cells, and deglycosylation Balachandran, N., and Hutt-Fletcher, L. M. (1985). Synthesis and pro-
experiments (not shown) demonstrate that the BHV-5/ cessing of glycoprotein gG of herpes simplex virus type 2. J. Virol.
54, 825–832.N569 US4 ORF encoded gG is modified by the addition
Baranowski, E., Dubuisson, J., van Drunen Littel-van den Hurk, S., Bab-of chondroitinsulfate as is the gG of BHV-1/Scho¨. We
iuk, L. A., Michel, A., Pastoret, P.-P., and Thiry, E. (1995). Synthesishypothesize that the synthesis, processing, and secretion
and processing of bovine herpesvirus-1 glycoprotein H. Virology 206,
of BHV-5 gG and gpgG are very similar or identical to 651–654.
the corresponding processes in BHV-1/Scho¨ infected Bartha, A., Haidu, G., Aldassy, P., and Paczolay, G. (1969). Occurence
of encephalomyelitis caused by infectious bovine rhinotracheitis vi-cells (Keil et al., 1996).
rus in calves in Hungary. Acta Vet. Acad. Sci. Hung. 19, 145–151.An interesting question arising from our results is why
Birnstiel, M. L., Busslinger, M., and Strub, K. (1985). Transcription termi-the vaccinia virus-expressed gG molecules do not con-
nation and 3* processing: The end is in site. Cell 41, 349–359.
tain glycosaminoglycans. This may be due to the specif- Bulach, D. M., and Studdert, M. J. (1990). Comparative genome mapping
ics of vaccinia virus replication or to the requirement for of bovine encephalitis herpesvirus, bovine herpesvirus 1, and buffalo
herpesvirus. Arch. Virol. 113, 17–34.another BHV-1 gene product(s).
Carillo, B. J., Pospischil, A., and Dahme, E. (1983). Pathology of bovineIn this report we show that the rabbit antisera obtained
necrotizing encephalitis in Argentina. Zbl. Vet. Med. B 30, 161–168.after infection with VacgG-5 and VacgG-1 cross react
Chou, P. Y., and Fasman, G. D. (1978). Prediction of the secondary
with gG and gpgG of BHV-5/N569 and BHV-1/Scho¨. This structure of proteins from their amino acid sequence. Adv. Enzymol.
contrasts with the results obtained in earlier studies in Relat. Areas Mol. Biol. 47, 145–148.
Chowdhury, S. I. (1995). Molecular basis of antigenic variation betweenwhich rabbit antisera raised against the same vaccinia
the glycoproteins C of respiratory bovine herpesvirus 1 (BHV-1) andrecombinants reacted in a type-specific manner (Keil et
neurovirulent BHV-5. Virology 213, 558–568.al., 1995). The only difference between the sera used in
Crabb, B. S., Nagesha, H. S., and Studdert, M. (1992). Identification of
the former study and that used in the present study is equine herpesvirus 4 glycoprotein G: A type specific secreted glyco-
that the previously used rabbit sera were obtained from protein. Virology 190, 143–154.
Crabb, B. S., and Studdert, M. (1993). Epitopes of glycoprotein G ofoutbred ‘‘Belgian giants’’ whereas the experiments de-
equine herpesvirus 4 and 1 located near the C termini elicit type-scribed in this report were performed with sera raised
specific antibody responses in the natural host. J. Virol. 67, 6332–in outbred ‘‘Chinchilla bastards.’’ The differing results may
6338.
thus reflect race-specific variations in the antibody re- Devereux, J. P., Haeberli, P., and Smithies, O. (1984). A comprehensive
sponses. Immunoprecipitation experiments with sera set of sequence analysis for the VAX. Nucleic Acids Res. 12, 387–
395.from BHV-1 infected cattle demonstrated that sera from
AID VY 8203 / 6a21$$$221 10-14-96 13:41:15 viras AP: Virology
135BHV-5 US4 GENE AND GENE PRODUCTS
Drillien, R., amd Spehner, D. (1983). Physical mapping of vaccinia virus Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982). ‘‘Molecular Cloning:
A Laboratory Manual.’’ Cold Spring Harbor Laboratory, Cold Springtemperature-sensitive mutations. Virology 131, 385–393.
Harbor, NY.Engels, M., Giulani, C., Wild, P., Beck, T. M., Loepfe, E., and Wyler, R.
Mayfield, J. E., Good, P. J., Vanoort, H. J., Campbell, A. R., and Reed,(1987). The genome of bovine herpesvirus 1 (BHV-1) exhibiting a
D. E. (1983). Cloning and cleavage site mapping of DNA from bovineneuropathogenic potential compared to known BHV-1 strains by re-
herpesvirus 1 (Cooper strain). J. Virol. 47, 259–264.striction site mapping and cross-hybridization. Virus Res. 6, 57–73.
McLauchlan, J., Gaffney, D., Whitton, J. L., and Clements, J. B. (1985).Fehler, F., Herrmann, J. M., Saalmu¨ller, A., Mettenleiter, T. C., and Keil,
The consensus sequence YGTGTTYY located downstream from theG. M. (1992). Glycoprotein IV of bovine herpesvirus 1-expressing cell
AATAAA signal is required for efficient formation of mRNA 3* termini.line complements and rescues a conditionally lethal viral mutant. J.
Nucleic Acids Res. 13, 1347–1366.Virol. 66, 831–839.
Rapp, M., Messerle, M., Bu¨hler, B., Tannheimer, M., Keil, G. M., andFrench, E. L. (1962). A specific virus encephalitis in range calves: Isola-
Koszinowski, U. H. (1992). Identification and expression of the murinetion and characterization of the causal agent. Aust. Vet. J. 38, 555–
cytomegalovirus glycoprotein B gene and its expression by reomi-556.
nant vaccinia virus. J. Virol. 66, 4399–4406.Fitzpatrick, D. R., Babiuk, L. A., and Zamb, T. J. (1989). Nucleotide se-
Rea, T. J., Timmons, J. G., Long, G. W., and Post, L. E. (1985). Mappingquence of bovine herpesvirus type 1 glycoprotein gIII, a structural
and sequence of the gene for the pseudorabies virus glycoproteinmodel for gIII as a new member of the immunoglobulin superfamily,
which accumulates in the medium of infected cells. J. Virol. 54, 21–and implications for the homologous glycoproteins of other herpesvi-
29.ruses. Virology 173, 46–57.
Richman, D. D., Buckmaster, A., Bell, S., Hodgman, C., and Minson,Gibbs, E. P. J., and Rweyemamu, M. M. (1977). Bovine herpes viruses.
A. C. (1986). Identification of a new glycoprotein of herpes simplexPart I. Bovine herpesvirus 1. Vet. Bull. (London) 47, 317–343.
virus type 1 and genetic mapping of the gene that codes for it. J.Kaashoek, M. J., Rijsewijk, F. A. M., Ruuls, R. C., Keil, G. M., Thiry, E.,
Virol. 57, 647–655.Pastoret, P.-P., and van Oirschot, J. T. (1996). Virulence, immunoge-
Roizman, B., Norrild, B., Chan, C., and Perreira, L. (1984). Identificationnicity and reactivation of bovine herpesvirus 1 mutants with a dele-
and preliminary mapping with monoclonal antibodies of a herpestion in the gC, gG, gI or gE gene. Vet. Microbiol., in press.
simplex virus 2 glycoprotein lacking a known type 1 counterpart.
Keil, G. M., Ebeling-Keil, A., and Koszinowski, U. H. (1987). Sequence
Virology 133, 242–247.
and structural organization of murine cytomegalovirus immediate-
Roizman, B., Desrosiers, R. C., Fleckenstein, B., Lopez, C., Minson, A. C.,
early gene 1. J. Virol. 54, 1901 –1908.
and Studdert, M. J. (1992). The family herpesviridae: An update. Arch
Keil, G. M., Engelhardt, T., and Enz, M. (1995). Characterization of BHV-
Virol. 123, 425–449.
1 and BHV-5 glycoprotein G, a secreted proteoglycan. In ‘‘Immunobi- Seal, B. S., and Whetstone, C. A. (1994). Immediate early gene expres-
ology of Viral Infections’’ (M. Schwyzer and M. Ackermann, Eds.), sion and gene mapping comparisons among isolates of bovine her-
Fondation Marcel Me´rieux, Lyon, France. pesvirus 1 and 5. Vet. Microbiol. 38, 369–384.
Keil, G. M., Engelhardt, T., Karger, A., and Enz, M. (1996). Bovine Herpes- Strube, W., Floß, G., Thein, P., and Keil, G. M. (1992). Vaccines based
virus 1 US Open reading frame 4 encodes a glycoproteoglycan. J. on modified bovine herpes viruses. U. S. Patent Application No. P
Virol. 70, 3032–3038. 41 41 400.4.
Kimman, T., deWind, N., Oei-Lie, N., Pol, J., Berns., A., and Gielkens, A. Telford, E. A., Watson, M. S., McBride, K., and Davison, A. J. (1992). The
(1992). Contribution of single genes within the unique short region DNA sequence of equine herpesvirus-1. Virology 189, 304–316.
of Aujeszky’s disease virus (suid herpesvirus type 1) to virulence, Thomson, D. E., Marchioli, C. E., Yancey, Jr., R. C., and Post, L. E. (1987).
pathogenesis and immunogenicity. J. Gen. Virol. 73, 243–251. Replication and virulence of pseudorabies virus mutants lacking gly-
Kozak, M. (1986). Point mutations define a sequence flanking the AUG coprotein X. J. Virol. 61, 229–232.
initiator codon that modulates translation by eucaryotic ribosomes. Tikoo, S. K., Fitzpatrick, D. R., Babiuk, L. A., and Zamb, T. J. (1990). Mo-
Cell 44, 283–292. lecular cloning, sequencing and expression of functional bovine her-
Kreil, G. (1981). Transfer of proteins across membranes. Annu. Rev. pesvirus 1 glycoprotein IV in transfected bovine cells. J. Virol. 64,
Biochem. 50, 317–348. 5132–5142.
Leung-Tack, P., Audonnet, J.-C., and Riviere, M. (1994). The complete Whitbeck, J. C., Bello, L. J., and Lawrence, W. C. (1988). Comparison of
nucleotide sequence and the genetic organization of the short unique the bovine herpesvirus type 1 gI gene and the herpes simplex virus
region (US) of the bovine herpesvirus type 1 (ST) strain. Virology 199, type 1 gB gene. J. Virol. 62, 3319–3327.
409–421. Wyler, R., Engels, M., and Schwyzer, M. (1989). Infectious bovine rhino-
Longnecker, R., and Roizman, B. (1987). Clustering of genes dispens- tracheitis/vulvovaginitis (BHV-1). In ‘‘Herpesvirus Diseases of Cattle,
able for growth in culture in the S component of the HSV-1 genome. Horses and Pigs. Developments in Vererinary Virology’’ (G. Wittmann,
Ed.), pp. 1–72. Kluwer, Dordrecht, Netherlands/Norwell, MA.Science 236, 573–576.
AID VY 8203 / 6a21$$$221 10-14-96 13:41:15 viras AP: Virology
